Medical Cannabis Western Australia: online assessment from Perth to regional WA
A telehealth consultation can remove kilometres from the first conversation. The same clinical, Commonwealth and Western Australian requirements still sit behind any prescription.
Book a Medicanna consultationCheck eligibility firstPatients in Western Australia can discuss medicinal cannabis with an appropriately authorised practitioner, including by telehealth when remote assessment is clinically suitable. Most medicinal cannabis products remain unapproved therapeutic goods, so Commonwealth access requirements may apply; WA also regulates Schedule 8 medicinal cannabis through its Monitored Medicines framework.
For a patient in Perth, the practical issue may be fitting an appointment around work and travel. For someone in Albany, Geraldton, Kalgoorlie, Broome, Karratha or Esperance, the harder part can come after the consultation: pharmacy stock, prescription requirements, delivery time, follow-up and access to examination or investigations when needed.
Telehealth changes the distance to the clinician. It does not change the threshold for treatment.
National medical cannabis guide2.6 million square kilometres. One clinical standard.
Across Western Australia, the clinical standard stays constant. What changes with distance is the practical path after assessment—particularly pharmacy stock, delivery and access to local care.
Telehealth can reduce cross-city travel. Pharmacy access is less distance-dependent, although stock and lawful dispensing of the particular prescription still need to be confirmed.
Patients around Bunbury and the wider South West may use telehealth for suitable assessment and follow-up while arranging dispensing locally or by delivery. Examination, pathology or imaging may still require local care.
Geraldton, Albany, Kalgoorlie and Esperance illustrate why pharmacy supply and delivery should be considered before assuming a prescription means immediate access to medicine.
For patients around Broome, Karratha and remote communities, telehealth may remove substantial travel for suitable consultations. It cannot replace urgent care, examination or investigations when clinically required.
What actually shapes a prescribing decision
Clinical judgement comes first
These are domains a practitioner may need to explore. Booking by telehealth creates no agreement to prescribe.
Symptoms or diagnosis, duration and effect on function.
Treatments already tried, their duration and what happened.
Current medicines, interactions and additive adverse effects.
Mental-health history, substance use, pregnancy or breastfeeding, cardiovascular instability and other relevant factors.
Driving, safety-sensitive work, caring responsibilities and possible cognitive effects.
How benefit, adverse effects and ongoing need would be reviewed.
Full prescription assessment guide Safety and standards guide
WA changed its Schedule 8 rules. The detail matters.
Most medicinal cannabis products are not registered on the ARTG. Access to an unapproved product generally uses a TGA pathway such as the Special Access Scheme or Authorised Prescriber scheme.
Medicinal products containing cannabidiol only are generally Schedule 4 prescription medicines under the WA framework, subject to applicable Commonwealth and prescribing requirements.
Medicinal cannabis products containing THC are Schedule 8 controlled medicines and are monitored through ScriptCheckWA and the WA Monitored Medicines Prescribing Code.
Since the revised Code commenced on 12 December 2024, a medical practitioner or nurse practitioner who meets the Code's prescriber, patient and product criteria may prescribe Schedule 8 medicinal cannabis without separate CEO authorisation. Nurse practitioners gained this prescribing authority under the same reform and always require a TGA SAS-B approval regardless of CEO authorisation status. Patient-specific CEO authorisation remains required where: the patient is under 18; the patient is drug dependent, oversupplied, or has a substance-use disorder history in the past five years; the patient has a history of psychosis or other psychiatric comorbidity; or the prescribed dose exceeds 40mg THC per day for oral products or 300mg THC per day for inhaled or vaporised products.
This is a regulatory overview, not a substitute for the current Code or individual legal/clinical advice.
WA Health medicinal cannabis guidance ↗ TGA access pathways ↗
Plan the pharmacy step before expecting supply.
WA Health says medicinal cannabis prescriptions can be dispensed at pharmacies in Western Australia. A pharmacy still needs to lawfully dispense the prescription and obtain the prescribed product. WA guidance also says product substitution is not appropriate simply because stock is unavailable; the pharmacist should contact the prescriber and an alternative product may require a new prescription.
Assessment
Clinical suitability is considered independently.
Prescription
If issued, it must meet applicable requirements.
Pharmacy
Stock, verification and dispensing are pharmacy matters.
Regional supply
Delivery time and local availability can matter more outside Perth.
Medication sales are not a DocTel revenue stream. Prescribing remains an independent clinical decision.
A prescription does not switch off WA's THC-presence rule.
WA Health states that it is an offence to drive with THC present in your system regardless of whether the THC came from prescribed medicinal cannabis or illicit cannabis. This presence-based offence—driving with a specified drug in oral fluid—applies regardless of impairment or prescription status. A separate, more serious drug-impaired driving offence requires evidence that the driver was not capable of proper control of the vehicle, and can involve a driver assessment or blood test.
CBD-only treatment is different from THC-containing treatment, but patients should confirm what their prescribed product contains and discuss impairment or medicine interactions with their practitioner or pharmacist.
WA drug-driving guidance ↗What you pay upfront is rarely what you pay overall.
Total treatment cost can include clinical review, medicine, dispensing and—particularly for regional patients—delivery. Product prices vary and most medicinal cannabis is supplied privately rather than through the PBS.
See the full cost guideBook a Medicanna consultation- Initial consultation: assessment; prescription not guaranteed.
- Follow-up: benefit, adverse effects and ongoing suitability.
- Medicine + dispensing: separate from DocTel's consultation fee.
- Delivery: potentially more relevant in regional and remote WA.
Straight answers to the questions that come up most
Can I have a medicinal cannabis consultation by telehealth in Western Australia?
Telehealth can be used when the practitioner considers remote assessment clinically appropriate. It does not guarantee prescribing, and some situations require examination, investigations or other care.
Which practitioners can prescribe medicinal cannabis in WA, and do they need separate approval?
Medical practitioners and, since the December 2024 Code changes, nurse practitioners can both prescribe medicinal cannabis where clinically appropriate. Nurse practitioners always need a TGA SAS-B approval regardless of CEO authorisation status. For either prescriber, separate WA CEO authorisation is only required in specified higher-risk circumstances.
Does every THC prescription need separate WA Health approval?
No. Under the Monitored Medicines Prescribing Code that commenced in December 2024, qualifying practitioners can prescribe Schedule 8 medicinal cannabis without separate CEO authorisation when all specified criteria are met. Patient-specific authorisation remains necessary when those criteria are not met.
What is ScriptCheckWA and why can it matter?
ScriptCheckWA is WA's real-time prescription monitoring system for monitored medicines. It helps prescribers identify current monitored-medicine prescriptions, repeats and potential oversupply.
Can Perth patients complete the whole process online?
The consultation and follow-up may be suitable for telehealth, but the entire care pathway is not automatically online. Examination or investigations may be required, and a prescription must then be lawfully dispensed.
What should regional WA patients organise before dispensing?
Confirm which pharmacy can dispense the prescription, stock availability, expected delivery timing and how follow-up will occur. A prescription does not guarantee immediate local stock.
Can a WA pharmacist substitute another cannabis product if mine is unavailable?
WA Health guidance says substitution is not appropriate simply because a medicinal cannabis product is unavailable. The pharmacist should contact the prescriber, and an alternative product may require a new prescription.
Can I drive in WA if my THC medicine is prescribed?
A prescription does not provide a general exemption from WA's THC presence offence. WA Health states that driving with THC present is an offence regardless of whether it came from prescribed medicinal cannabis or illicit cannabis.
How much does medicinal cannabis cost in Western Australia?
Total cost varies with consultation and follow-up fees, the medicine selected if prescribed, pharmacy charges and possible delivery. DocTel does not add a medication markup or receive a pharmacy commission.
Does booking a consultation mean I will receive a prescription?
No. The consultation is an assessment. The practitioner decides whether treatment is clinically appropriate and lawful after considering history, previous care, current medicines, risks and applicable regulatory requirements.
Current regulatory references: WA Department of Health medicinal cannabis guidance; WA Monitored Medicines framework; WA Road Safety Commission; and TGA medicinal cannabis access pathways.
Start with the clinical question, wherever you are in Western Australia.
Check whether a DocTel Medicanna assessment may be appropriate. Eligibility screening and consultation do not guarantee prescribing.
Book your Medicanna consultationCheck eligibility first